Wikidata

(Q39655492)

English

A mechanistic rationale for combining alemtuzumab and rituximab in the treatment of ALL.

scientific article published on 15 September 2010

In more languages

Statements

title
A mechanistic rationale for combining alemtuzumab and rituximab in the treatment of ALL. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20844239
retrieved
13 September 2017
author
Marieke Griffioen
object named as
Marieke Griffioen
series ordinal
4
0 references
author name string
Bart A Nijmeijer
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20844239
retrieved
13 September 2017
Marianke L J van Schie
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20844239
retrieved
13 September 2017
Constantijn J M Halkes
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20844239
retrieved
13 September 2017
Roelof Willemze
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20844239
retrieved
13 September 2017
J H Frederik Falkenburg
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20844239
retrieved
13 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39655492&oldid=1561082435"